Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III - Summary - MDSpire

Editorial: Progress in Precision Medicine for Immune-Mediated Disorders: Utilizing Big Data and Artificial Intelligence to Explore Variability in Inflammatory Responses, Volume III

  • By

  • Xu-jie Zhou

  • Le-ting Zhou

  • Celine C. Berthier

  • Swapan K. Nath

  • June 2, 2026

Share

Objective:

Revise to connect more directly to the advancements discussed in the volume.

Key Findings:
  • Remove any implications about the significance of findings that are not directly supported.
Interpretation:

Remove editorial language to maintain objectivity.

Limitations:
  • Explicitly tie limitations to the findings discussed.
Conclusion:

Omit editorial interpretation to comply with guidelines.

Original Source(s)

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III

  • by Xu-jie Zhou, Le-ting Zhou, Celine C. Berthier, Swapan K. Nath

  • June 2, 2026

Related Content

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

Labial-gland artificial intelligence model screening for autoimmune thyroiditis among patients with connective tissue disease

Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time